Italian authorities have closed a criminal investigation into Stefano Stracciari, a former aesthetic doctor and surgeon struck off the medical register, for alleged negligent injury, use of expired and defective medicines, and importing counterfeit medical devices. The case, involving at least four former patients, underscores regulatory risks for overseas buyers sourcing aesthetic devices and injectables from Italy.
Investigation details
Bologna prosecutor Luca Venturi has closed the investigation into Stracciari, a step that typically precedes a request for indictment. The former doctor, already involved in multiple legal cases, is accused of causing harm to patients through the use of substandard pharmaceuticals and falsified medical devices.
Patient harm and illegal practice
At least four former patients are named as injured parties in the case. Stracciari was jailed in 2025 after being caught by Italian TV program Le Iene and later by NAS health authorities continuing to see patients in his studio despite police seals. He had been previously suspended from practice.
Prior conviction for silicone oil use
On May 26, Stracciari was sentenced to six months in first instance for negligent injury to a 45-year-old woman. In 2023, at his Pianoro (Bologna) clinic, she underwent a cheek thread-lift procedure but was left disfigured after he illegally used silicone oil, which has been banned in Italy since 1993.
Regulatory and channel signals
This case highlights the importance of verifying device authenticity and supplier compliance when sourcing aesthetic products from Italy. Overseas distributors and clinic buyers should ensure that injectables and devices are CE-marked, traceable, and sourced from authorized manufacturers to avoid counterfeit or expired stock that could lead to legal liability and reputational damage.
Source: Read the original report | Published: June 03, 2026